DOJ: Google must sell Chrome to end monopoly

Date:

Share post:


The United States Department of Justice argued Wednesday that Google should divest its Chrome browser as part of a remedy to break up the company’s illegal monopoly in online search, according to a U.S District Court of the District of Columbia filing. Google would not be allowed to re-enter the search market for five years if the DOJ’s proposed remedy is approved.

Ultimately, it will be up to U.S. District of Columbia District Court Judge Amit Mehta to decide what Google’s final punishment will be, a decision that could fundamentally change one of the world’s largest businesses and alter the structure of the internet as we know it. That phase of the trial is expected to kick off sometime in 2025.

Judge Mehta ruled in August that Google was an illegal monopoly for abusing its power over the search business. The judge also took issue with Google’s control of various gateways to the internet, and the company’s payments to third parties in order to retain its status as a default search engine. 

The Justice Department proposed other remedies to address the search giant’s monopoly, including that Google spin off its Android mobile operating system. Prosecutors also argued the company should be prohibited from entering into exclusionary third-party contracts with browser or phone companies, such as Google’s contract to be the default search engine on all Apple products.

The Wednesday filing confirms earlier reports that prosecutors were considering pushing Google to spin off Chrome, which controls about 61% of the browser market in the U.S., according to web traffic service StatCounter.

Google did not immediately respond to TechCrunch’s request for comment.

This story is developing…



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

WhatsApp will finally let you unsubscribe from business marketing spam

WhatsApp Business has grown to over 200 million monthly users over the past few years. That means there...

OneCell Diagnostics bags $16M to help limit cancer reoccurrence using AI

Cancer, one of the most life-threatening diseases, is projected to affect over 35 million people worldwide in...

India’s Arzooo, once valued at $310M, sells in distressed deal

Arzooo, an Indian startup founded by former Flipkart executives that sought to bring “best of e-commerce” to...

OpenAI accidentally deleted potential evidence in NY Times copyright lawsuit

Lawyers for The New York Times and Daily News, which are suing OpenAI for allegedly scraping their...

Nvidia’s CEO defends his moat as AI labs change how they improve their AI models

Nvidia raked in more than $19 billion in net income during the last quarter, the company reported...

Snowflake snaps up data management company Datavolo

Cloud giant Snowflake has agreed to acquire Datavolo, a data pipeline management company, for an undisclosed sum....

Solar power magnate Gautam Adani and others indicted over alleged $250M bribery scheme

Billionaire Gautam Adani and several executives at his company, the Indian conglomerate Adani Group, have been indicted...

‘PDF to Brainrot’ study tools are a strange iteration on a TikTok trend

Several AI-based study tools are capitalizing on a “PDF to Brainrot” trend, which will read the text...